TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,830,000 | +1167.4% | 331,989 | +600.8% | 0.01% | +500.0% |
| Q2 2021 | $460,000 | -37.9% | 47,371 | -31.3% | 0.00% | 0.0% |
| Q1 2021 | $741,000 | -54.6% | 68,950 | -37.8% | 0.00% | -66.7% |
| Q4 2020 | $1,632,000 | +120.2% | 110,924 | +112.8% | 0.00% | +50.0% |
| Q3 2020 | $741,000 | +112.3% | 52,133 | +20.8% | 0.00% | 0.0% |
| Q2 2020 | $349,000 | – | 43,143 | +43043.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 100 | -95.2% | 0.00% | – |
| Q3 2018 | $12,000 | 0.0% | 2,100 | +5.0% | 0.00% | – |
| Q2 2018 | $12,000 | -14.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|